Abstracts and Articles

MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization.

Wang Weilang (W);Zhang Xiuming (X);Yu Yixing (Y);Feng Feng (F);Cai Wu (W);Zhou Shuwei (S);Zhang Shuhang (S);Li Binrong (B);Xia Tianyi (T);Ju Shenghong (S);Wang Yuan-Cheng (YC)

Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors.

Abdelsalam Mohamed E (ME);Ahrar Kamran (K);Sheth Rahul A (RA);Shah Ketan Y (KY);Yevich Steven (S);Gurusamy Varshana (V);Odisio Bruno C (BC);Tam Alda L (AL);Mahvash Armeen (A);Habibollahi Peiman (P)

Arterial-Washout Temporal Profiling in CEUS LI-RADS: A Diagnostic Algorithm for Reducing Hepatocellular Carcinoma Misclassification.

Wang Yang (Y);Zhu Zhixian (Z);Zhu Mengjiao (M);Wu Size (S)

Proton Beam Therapy Boosts Outcomes of Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma: A Propensity Score Analysis.

Kuo Yuan-Hung (YH);Teng Wei (W);Lin Po-Ting (PT);Chen Yen-Hao (YH);Su Chung-Wei (CW);Shen Eric Yi-Liang (EY);Huang Bing-Shen (BS);Wu Tsung-Han (TH);Cheng Jen-Yu (JY);Hsieh Yi-Chung (YC);Chen Wei-Ting (WT);Hung Chao-Hung (CH);Lin Shi-Ming (SM);Lin Chen-Chun (CC);Wang Jing-Houng (JH);Lin Chun-Yen (CY)

Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B.

Sasaki Ryu (R);Shimose Shigeo (S);Saeki Issei (I);Ito Takanori (T);Takeuchi Yasuto (Y);Tani Joji (J);Tomonari Tetsu (T);Sasaki Kyo (K);Kakizaki Satoru (S);Hatanaka Takeshi (T);Miuma Satoshi (S);Shirono Tomotake (T);Iwamoto Hideki (H);Tanabe Norikazu (N);Yamamoto Takafumi (T);Kanayama Yuki (Y);Naganuma Atsushi (A);Nishina Sohji (S);Takayama Tetsuji (T);Kobara Hideki (H);Otsuka Motoyuki (M);Kawashima Hiroki (H);Takami Taro (T);Kawaguchi Takumi (T);Miyaaki Hisamitsu (H); ()

Real-World Survival Outcomes of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma Patients With Hepatitis B Virus Infection: A Hospital-Based Cohort Study.

Dung Nguyen Thi (NT);Binh Nguyen Huy (NH);Quang Bui Vinh (BV);Hien Truong Thu (TT);Phuong Pham Cam (PC);Thang Vu Hong (VH)

Getting to Implementation: applying data-driven implementation strategies to improve guideline concordant surveillance for hepatocellular carcinoma.

Yakovchenko Vera (V);Kang Chaeryon (C);Neely Brittney (B);Lamorte Carolyn (C);McCurdy Heather (H);Scott Dawn (D);Nobbe Anna (A);Robins Gwen (G);Ekanem Nsikak R (NR);Merante Monica (M);Gibson Sandra (S);Spoutz Patrick (P);Chia Linda (L);Gonzalez Rachel I (RI);Chinman Matthew J (MJ);Ross David (D);Chartier Maggie (M);Beste Lauren A (LA);Bajaj Jasmohan S (JS);Taddei Tamar (T);Morgan Timothy R (TR);Rogal Shari S (SS)

Burden of primary sclerosing cholangitis in Sweden (2002-2020): Incidence, outcomes, healthcare utilization, and costs.

Bergquist Annika (A);Kachru Nandita (N);Aldvén Martina (M);Ström Oskar (O);Skröder Helena (H);Toresson Grip Emilie (E);Hagström Hannes (H)

Enhancing prediction of incisional hernia in liver transplant patients: performance assessment and stepwise revision of a prognostic model.

Dhaene Sam (S);Ghazinoer Anna (A);Allaeys Mathias (M);Berrevoet Frederik (F)

Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia.

Alqahtani Saleh A (SA);AlMuhaidib Shadan (S);Raptis Dimitri A (DA);Al-Hamoudi Waleed K (WK);Reddy K Rajender (KR);Broering Dieter C (DC);Alghamdi Saad A (SA); ()

Incomplete Immune Tolerance in Pediatric ABO-Incompatible Liver Transplantation: Insights From Donor-Specific Antibody Titers.

Qu Wei (W);Liu Ying (Y);Cai Ru-Zhou (RZ);Zhu Zhi-Jun (ZJ);Sun Li-Ying (LY);Wei Lin (L);Zeng Zhi-Gui (ZG)

Pulmonary nodules near fissures in hepatocellular carcinoma: assessing their clinical significance.

Machado Leonardo Chaves (LC);Szarf Gilberto (G);Teles Gustavo Borges da Silva (GBDS);Yokoo Patrícia (P);Chate Rodrigo Caruso (RC);Fonseca Eduardo Kaiser Ururahy Nunes (EKUN)

Longitudinal biomarker progression and validation for predicting operational tolerance in a prospective multicenter liver transplantation immunosuppression withdrawal trial.

López-Díaz Gloria (G);Sánchez-Lorencio María Isabel (MI);Iñarrairaegui Mercedes (M);González-Diéguez María Luisa (ML);Cadahía Valle (V);Otero-Ferreiro Alejandra (A);Vázquez-Millán María Ángeles (MÁ);Romero-Cristóbal Mario (M);Salcedo Magdalena (M);Lorente-Pérez Sara (S);Sánchez-Antolín Gloria (G);de la Peña Jesús (J);Ramírez Pablo (P);Pata María P (MP);Baroja-Mazo Alberto (A);Herrero José I (JI);Pons José Antonio (JA)

Transient elastography and fibrosis-4 index as predictors of hepatocellular carcinoma in hepatitis C virus patients with sustained virological response.

da Silva Paula G F (PGF);Barrocas Juliana B P (JBP);Perazzo Hugo (H);Villela-Nogueira Livia (L);Peixoto Helena R (HR);Pereira Gustavo H S (GHS);Braga Lailiane N P (LNP);Chinzon Miriam (M);de Silva Joyce R L (JRL);Fernandes Flávia F (FF);Villela-Nogueira Cristiane A (CA)

Comparison of the efficacy of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma: A retrospective study.

Lei Zi-Lun (ZL);Tan Zheng-Li (ZL);Luo Yun-Hai (YH);Yang Ming (M);Wang Jin-Lin (JL);Qin Zheng (Z);Liu Yan-Yao (YY)

A cost-effectiveness analysis of a new and more effective treatment for unresectable hepatocellular carcinoma-from a Chinese perspective.

Chen Jianhua (J);Dong Zuojun (Z);Shou Bingchao (B);Huang Zimeng (Z);Huang Li (L);Sun Guojun (G)

Preoperative differentiation of primary liver cancer subtypes: An MRI-based multiclass classification model integrating radiomic and clinicoradiological characteristics.

Wang Wenhao (W);Liu Xinai (X);Yang Chun (C);Li Yubo (Y)

Development of a nomogram for predicting microvascular invasion in patients with hepatocellular carcinoma.

Li Jun (J);Huo Shengjun (S);Ma Jun (J);Ren Liying (L);Liu Lingling (L);Lu Yu (Y);Tang Songyun (S);Chen Dongbo (D);Jin Lei (L);Liao Weijia (W)